Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT06607939
ORB-021 In Patients With Advanced Solid Tumors (OR2-01)
Sponsor: Orionis Biosciences Inc
Conditions
Advanced Solid Tumors Cancer
Interventions
ORB-021
Updated 3 times since 2024 Last updated: Feb 9, 2026 Started: Nov 21, 2024 Primary completion: May 29, 2026 Completion: May 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Advanced Solid Tumors Cancer, this trial is actively recruiting participants. The trial is conducted by Orionis Biosciences Inc and has accumulated 3 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
3 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE1
-
Feb 2025 — Feb 2026 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Orionis Biosciences Inc
Data source: Orionis Biosciences Inc
For direct contact, visit the study record on ClinicalTrials.gov .